Psillas G, Constantinidis J, Printza A, Vital V
Hals-Nasen-Ohren-Klinik, Kopf- und Halschirurgie, AHEPA-Hospital, Aristoteles-Universität, 54006, Thessaloniki, Griechenland.
HNO. 2007 Aug;55(8):625-9. doi: 10.1007/s00106-006-1496-2.
In this retrospective study, we assessed the long-term prognostic value of the minimal nerve excitability test (NET) by comparing the results it yielded with the House-Brackmann (HB) index in patients with the most common types of facial paralysis, Bell's palsy and traumatic facial palsy.
Three hundred and fifty patients aged 9-85 years (mean age 42.4 years; 156 male and 194 female), all of whom were treated initially with the same steroid therapy, entered on study. Patients in whom decompression surgery had been performed were excluded so as to avoid falsely optimistic prognoses. The 350 study patients were divided into two groups: group 1 was made up of 250 with Bell's palsy and group 2, of 100 with nonpenetrating traumatic facial palsy following temporal bone fracture. The NET was conducted repeatedly in all patients for 3 weeks from the start of day 3 of treatment, the value recorded on day 14 being used in the evaluation. For each patient, the result of the NET was recorded as 'normal', 'diminished' or 'without response' according to the difference between the two sides of the face. The final HB grading was determined after 1 year to check for the agreement between the electrical prognosis and the clinical outcome and thus the reliability of the prognosis indicated by the NET.
The results indicate that a normal NET forecast a satisfactory outcome that could be classed as HB I-II in almost all the patients in both groups. Among patients who had no response on NET, 85% of those with Bell's palsy and 90% of those with traumatic facial palsy failed to recover nerve function. Diminished nerve excitability proved to be a sign of a relatively favourable prognosis: 74% of patients in each group recovered normal facial function.
The NET is a method of investigation that is easily applied and can make a positive contribution to the assessment of prognosis in Bell's palsy and in traumatic facial palsy, reflecting the functional state of the facial nerve reliably in most of cases.
在这项回顾性研究中,我们通过比较最常见的面瘫类型(贝尔面瘫和创伤性面瘫)患者的最小神经兴奋性测试(NET)结果与House-Brackmann(HB)指数,评估了NET的长期预后价值。
350例年龄在9至85岁(平均年龄42.4岁;男性156例,女性194例)的患者纳入研究,所有患者最初均接受相同的类固醇治疗。已接受减压手术的患者被排除,以避免预后过于乐观。350例研究患者分为两组:第1组由250例贝尔面瘫患者组成,第2组由100例颞骨骨折后非穿透性创伤性面瘫患者组成。从治疗第3天开始,对所有患者重复进行3周的NET测试,评估时采用第14天记录的值。根据面部两侧的差异,将每位患者的NET结果记录为“正常”、“减弱”或“无反应”。1年后确定最终的HB分级,以检查电生理预后与临床结果之间的一致性,从而验证NET所提示预后的可靠性。
结果表明,正常的NET预示着几乎所有两组患者都能获得可归类为HB I-II级的满意结果。在NET无反应的患者中,85%的贝尔面瘫患者和90%的创伤性面瘫患者未能恢复神经功能。神经兴奋性减弱被证明是预后相对较好的标志:每组74%的患者恢复了正常面部功能。
NET是一种易于应用的检查方法,可为贝尔面瘫和创伤性面瘫的预后评估做出积极贡献,在大多数情况下能可靠地反映面神经的功能状态。